Choose the safety of EMERPHED® ready‑to‑use ephedrine.
Commercially prepared. FDA approved.

Choose the safety of EMERPHED® ready‑to‑use ephedrine.
Commercially prepared. FDA approved.

Choose the safety of EMERPHED® ready‑to‑use ephedrine.
Commercially prepared. FDA approved.

The first FDA-approved, patented, ready‑to‑use ephedrine.

Want one less thing to worry about in the OR? Choose the simplicity, stability, and safety of EMERPHED® ready-to-use ephedrine from Nexus Pharmaceuticals.

Ready to use. Less waste.

And no mixing means no mix-ups.

Prescribing Information

Redefining standards of care—the benefits of EMERPHED®

Simple

No compounding

EMERPHED® can be administered by any trained staff with less chance for error.

Stable

2-year shelf-life

EMERPHED® is ready when you need it
with less frequent
re-stocking/ordering.

Safe

No diluting or mixing

EMERPHED® is easier to use with less waste and chance for error.

Share and compare.
Take our short survey.

What does ready-to-use mean for your OR protocol? Compare your process with that of your colleagues.

No mixing.
No mix-ups.

See why the FDA recommends the use of non-compounded, manufacturer-prepared products.

What important safety infomation should I know?

CONTRAINDICATIONS
None

WARNINGS AND PRECAUTIONS
EMERPHED® can cause pressor effects with concomitant use with oxytocic drugs. Can also cause tachyphylaxis with repeated administration of ephedrine.

ADVERSE REACTIONS
Most common adverse reactions during treatment: nausea, vomiting, and tachycardia.
To report SUSPECTED ADVERSE REACTIONS, contact Nexus Pharmaceuticals at (855) 642-2594 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS
Can include: interactions that augment pressor effect; interactions that antagonize the pressor effect; guanethidine; rocuronium; epidural anesthesia; theophylline; cardiac glycosides.

OVERDOSAGE
Overdose of EMERPHED® can cause a rapid rise in blood pressure. In the case of an overdose, careful monitoring of blood pressure is recommended. If blood pressure continues to rise to an unacceptable level, parenteral antihypertensive agents can be administered at the discretion of the clinician.

INDICATIONS AND USAGE
Ephedrine Sulfate injection is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

For more information, see full Prescribing Information.

EPH-134-v1